 Peter Buttrick
Concepts (571)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 55 | 2018 | 968 | 3.670 |
Why?
| | Heart Ventricles | 20 | 2023 | 767 | 2.230 |
Why?
| | Myocardial Contraction | 23 | 2011 | 334 | 1.980 |
Why?
| | Heart Failure | 21 | 2023 | 2145 | 1.950 |
Why?
| | Protein Kinase C | 20 | 2014 | 257 | 1.950 |
Why?
| | Cardiomegaly | 21 | 2013 | 168 | 1.850 |
Why?
| | Ventricular Dysfunction, Right | 7 | 2023 | 228 | 1.670 |
Why?
| | Myocytes, Cardiac | 14 | 2022 | 495 | 1.540 |
Why?
| | Troponin I | 10 | 2013 | 75 | 1.270 |
Why?
| | Isoenzymes | 18 | 2002 | 302 | 1.220 |
Why?
| | Heart | 22 | 2022 | 637 | 1.110 |
Why?
| | Actin Cytoskeleton | 7 | 2011 | 104 | 0.940 |
Why?
| | Ventricular Function, Right | 6 | 2023 | 275 | 0.900 |
Why?
| | Muscle Proteins | 5 | 2025 | 221 | 0.880 |
Why?
| | Ventricular Remodeling | 9 | 2025 | 255 | 0.860 |
Why?
| | Cardiomyopathy, Dilated | 7 | 2025 | 378 | 0.860 |
Why?
| | Myosins | 18 | 2018 | 133 | 0.810 |
Why?
| | Ventricular Function, Left | 6 | 2025 | 524 | 0.760 |
Why?
| | Phosphorylation | 19 | 2016 | 1686 | 0.750 |
Why?
| | Heart-Assist Devices | 3 | 2012 | 536 | 0.730 |
Why?
| | Hypertension, Pulmonary | 8 | 2023 | 1749 | 0.680 |
Why?
| | Protein Kinase C-epsilon | 9 | 2007 | 26 | 0.660 |
Why?
| | Stroke Volume | 10 | 2025 | 589 | 0.650 |
Why?
| | Rats | 50 | 2013 | 5246 | 0.640 |
Why?
| | Myosin Light Chains | 4 | 2013 | 27 | 0.640 |
Why?
| | Carrier Proteins | 5 | 2022 | 732 | 0.640 |
Why?
| | Scientific Misconduct | 1 | 2019 | 12 | 0.630 |
Why?
| | Myocardial Infarction | 9 | 2013 | 1015 | 0.610 |
Why?
| | Sarcomeres | 7 | 2021 | 92 | 0.600 |
Why?
| | Physical Conditioning, Animal | 8 | 2006 | 229 | 0.590 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 5 | 2011 | 132 | 0.590 |
Why?
| | Neprilysin | 1 | 2018 | 47 | 0.570 |
Why?
| | Animals | 88 | 2023 | 34647 | 0.570 |
Why?
| | Editorial Policies | 1 | 2017 | 48 | 0.510 |
Why?
| | Gene Expression Regulation | 9 | 2019 | 2516 | 0.500 |
Why?
| | Calcium | 11 | 2011 | 1183 | 0.500 |
Why?
| | Cardiac Myosins | 2 | 2013 | 30 | 0.500 |
Why?
| | Myocardial Ischemia | 4 | 2019 | 247 | 0.500 |
Why?
| | Rats, Wistar | 17 | 2006 | 398 | 0.500 |
Why?
| | Adrenergic beta-Agonists | 5 | 2002 | 130 | 0.470 |
Why?
| | Histone Deacetylases | 2 | 2013 | 210 | 0.450 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1003 | 0.450 |
Why?
| | Periodicals as Topic | 1 | 2017 | 203 | 0.450 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2021 | 258 | 0.440 |
Why?
| | Serine | 3 | 2013 | 136 | 0.440 |
Why?
| | Apoptosis | 5 | 2002 | 2437 | 0.430 |
Why?
| | Aortic Valve Stenosis | 2 | 2013 | 218 | 0.420 |
Why?
| | Valproic Acid | 1 | 2013 | 47 | 0.410 |
Why?
| | Hydroxamic Acids | 1 | 2013 | 88 | 0.410 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 383 | 0.400 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2002 | 311 | 0.380 |
Why?
| | Gene Expression | 14 | 2017 | 1455 | 0.380 |
Why?
| | Isoproterenol | 6 | 2004 | 112 | 0.380 |
Why?
| | Recovery of Function | 3 | 2011 | 633 | 0.380 |
Why?
| | RNA, Messenger | 15 | 2017 | 2679 | 0.360 |
Why?
| | Models, Biological | 3 | 2021 | 1698 | 0.350 |
Why?
| | Heart Rate | 9 | 2025 | 798 | 0.330 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2025 | 320 | 0.330 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2021 | 222 | 0.320 |
Why?
| | Dobutamine | 5 | 2005 | 36 | 0.320 |
Why?
| | Mice | 27 | 2022 | 16620 | 0.310 |
Why?
| | Receptors, Adrenergic, beta | 3 | 2011 | 126 | 0.310 |
Why?
| | Phenotype | 3 | 2025 | 3051 | 0.310 |
Why?
| | Angiotensin Receptor Antagonists | 3 | 1997 | 89 | 0.300 |
Why?
| | Humans | 53 | 2025 | 128495 | 0.290 |
Why?
| | Phosphoserine | 2 | 2007 | 33 | 0.290 |
Why?
| | Disease Models, Animal | 11 | 2023 | 3947 | 0.290 |
Why?
| | Cattle | 6 | 2023 | 965 | 0.290 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2023 | 134 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 5 | 2016 | 453 | 0.280 |
Why?
| | Catecholamines | 5 | 2022 | 97 | 0.280 |
Why?
| | Enzyme Inhibitors | 6 | 2002 | 813 | 0.280 |
Why?
| | Muscle Strength | 1 | 2010 | 304 | 0.270 |
Why?
| | Tissue and Organ Procurement | 1 | 2010 | 288 | 0.270 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 198 | 0.270 |
Why?
| | Pharmacogenetics | 1 | 2008 | 172 | 0.260 |
Why?
| | Biophysics | 1 | 2007 | 69 | 0.260 |
Why?
| | NAD | 1 | 2007 | 72 | 0.260 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2006 | 69 | 0.260 |
Why?
| | Mitochondria, Heart | 1 | 2007 | 93 | 0.260 |
Why?
| | Glycolysis | 2 | 2012 | 293 | 0.260 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2006 | 67 | 0.260 |
Why?
| | Cytosol | 1 | 2007 | 215 | 0.260 |
Why?
| | Mice, Transgenic | 13 | 2018 | 2069 | 0.250 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 443 | 0.250 |
Why?
| | Signal Transduction | 10 | 2021 | 4825 | 0.240 |
Why?
| | Models, Animal | 1 | 2007 | 367 | 0.240 |
Why?
| | Hypertension, Renovascular | 3 | 1994 | 13 | 0.240 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 639 | 0.240 |
Why?
| | Hypertension | 5 | 2007 | 1236 | 0.240 |
Why?
| | Male | 39 | 2025 | 63043 | 0.230 |
Why?
| | Myosin Heavy Chains | 3 | 2004 | 173 | 0.230 |
Why?
| | Fibroblasts | 4 | 2020 | 937 | 0.230 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 844 | 0.230 |
Why?
| | MAP Kinase Signaling System | 1 | 2006 | 307 | 0.230 |
Why?
| | Calcineurin | 2 | 2002 | 91 | 0.230 |
Why?
| | Renin-Angiotensin System | 2 | 1996 | 79 | 0.230 |
Why?
| | Gene Transfer Techniques | 3 | 2000 | 162 | 0.210 |
Why?
| | Angiotensin II | 2 | 2001 | 93 | 0.210 |
Why?
| | Female | 49 | 2025 | 68266 | 0.210 |
Why?
| | GATA4 Transcription Factor | 2 | 2020 | 18 | 0.210 |
Why?
| | Chronic Disease | 2 | 2020 | 1692 | 0.210 |
Why?
| | Collagen | 3 | 2016 | 430 | 0.200 |
Why?
| | Cardiovascular Diseases | 3 | 2007 | 2001 | 0.200 |
Why?
| | Thromboxane A2 | 2 | 2002 | 11 | 0.200 |
Why?
| | Hemodynamics | 9 | 2011 | 1077 | 0.200 |
Why?
| | Cardiac Output, Low | 1 | 2002 | 66 | 0.190 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2001 | 21 | 0.190 |
Why?
| | Dilatation, Pathologic | 1 | 2001 | 60 | 0.190 |
Why?
| | Rats, Inbred Strains | 14 | 1992 | 362 | 0.190 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 633 | 0.180 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2002 | 95 | 0.180 |
Why?
| | Heart Diseases | 2 | 2019 | 347 | 0.180 |
Why?
| | Genetic Therapy | 3 | 2000 | 292 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2021 | 819 | 0.180 |
Why?
| | Calcium Signaling | 3 | 2011 | 233 | 0.180 |
Why?
| | Cyclosporine | 1 | 2001 | 171 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2004 | 175 | 0.180 |
Why?
| | Organ Size | 12 | 2001 | 441 | 0.180 |
Why?
| | Biomedical Research | 1 | 2007 | 633 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 941 | 0.180 |
Why?
| | Brachial Artery | 1 | 2002 | 185 | 0.170 |
Why?
| | Adaptation, Physiological | 4 | 2012 | 513 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2022 | 216 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 60 | 0.170 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2002 | 215 | 0.170 |
Why?
| | Blood Pressure | 11 | 2012 | 1712 | 0.170 |
Why?
| | Tetrazoles | 2 | 1997 | 37 | 0.170 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 178 | 0.170 |
Why?
| | Molecular Sequence Data | 8 | 2012 | 2822 | 0.170 |
Why?
| | Animals, Newborn | 5 | 2011 | 808 | 0.160 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2021 | 132 | 0.160 |
Why?
| | Cardiotonic Agents | 3 | 2005 | 124 | 0.160 |
Why?
| | Phototherapy | 1 | 2019 | 29 | 0.160 |
Why?
| | Cell Dedifferentiation | 1 | 2019 | 30 | 0.160 |
Why?
| | Cells, Cultured | 13 | 2021 | 4017 | 0.160 |
Why?
| | Cocaine | 2 | 1991 | 148 | 0.160 |
Why?
| | Circadian Clocks | 1 | 2019 | 44 | 0.160 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 28 | 0.160 |
Why?
| | Autophagosomes | 1 | 2018 | 19 | 0.160 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2018 | 25 | 0.160 |
Why?
| | Body Weight | 10 | 2001 | 933 | 0.150 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 231 | 0.150 |
Why?
| | Membrane Fusion | 1 | 2018 | 38 | 0.150 |
Why?
| | Imidazoles | 2 | 1997 | 229 | 0.150 |
Why?
| | In Vitro Techniques | 8 | 2011 | 1047 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 345 | 0.150 |
Why?
| | Hyperglycemia | 1 | 2002 | 326 | 0.150 |
Why?
| | Lysosomes | 1 | 2018 | 135 | 0.150 |
Why?
| | Amphiregulin | 1 | 2018 | 25 | 0.150 |
Why?
| | Echocardiography | 3 | 2009 | 624 | 0.150 |
Why?
| | Transfection | 4 | 2002 | 896 | 0.150 |
Why?
| | Adenosine Triphosphatases | 5 | 2005 | 161 | 0.150 |
Why?
| | Systole | 3 | 2005 | 190 | 0.150 |
Why?
| | Receptors, Histamine H2 | 1 | 2017 | 8 | 0.140 |
Why?
| | Filamins | 1 | 2018 | 28 | 0.140 |
Why?
| | In Situ Nick-End Labeling | 3 | 2002 | 117 | 0.140 |
Why?
| | Aging | 5 | 2008 | 1755 | 0.140 |
Why?
| | Physical Exertion | 3 | 1988 | 207 | 0.140 |
Why?
| | Period Circadian Proteins | 2 | 2019 | 10 | 0.140 |
Why?
| | Actomyosin | 1 | 1997 | 17 | 0.140 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2018 | 121 | 0.140 |
Why?
| | Enzyme Activation | 4 | 2002 | 797 | 0.140 |
Why?
| | Protein Kinase C beta | 6 | 2008 | 21 | 0.130 |
Why?
| | Activities of Daily Living | 1 | 2020 | 383 | 0.130 |
Why?
| | Coronary Circulation | 4 | 2004 | 137 | 0.130 |
Why?
| | Angiotensin I | 1 | 1996 | 7 | 0.130 |
Why?
| | Myofibrils | 2 | 2021 | 49 | 0.130 |
Why?
| | Patient Participation | 1 | 2020 | 409 | 0.130 |
Why?
| | Middle Aged | 12 | 2025 | 30921 | 0.130 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 5281 | 0.130 |
Why?
| | Sex Characteristics | 3 | 2006 | 722 | 0.130 |
Why?
| | Hypoxia | 4 | 2023 | 1035 | 0.130 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2015 | 11 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1996 | 175 | 0.120 |
Why?
| | Ultrasonography | 2 | 2012 | 712 | 0.120 |
Why?
| | Amino Acid Substitution | 2 | 2007 | 281 | 0.120 |
Why?
| | Coronary Artery Disease | 1 | 2002 | 676 | 0.120 |
Why?
| | Time Factors | 8 | 2009 | 6505 | 0.120 |
Why?
| | rho-Associated Kinases | 1 | 2015 | 83 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2015 | 94 | 0.120 |
Why?
| | Coronary Vessels | 2 | 1987 | 236 | 0.120 |
Why?
| | Heart Transplantation | 4 | 2011 | 711 | 0.120 |
Why?
| | Blotting, Western | 2 | 2015 | 1170 | 0.120 |
Why?
| | Atrial Natriuretic Factor | 2 | 2007 | 56 | 0.110 |
Why?
| | Tetracycline | 1 | 1994 | 12 | 0.110 |
Why?
| | Interleukin-18 | 1 | 2016 | 236 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1404 | 0.110 |
Why?
| | Amino Acid Sequence | 4 | 2012 | 2044 | 0.110 |
Why?
| | Renin | 1 | 1993 | 31 | 0.110 |
Why?
| | Cardiac Output | 3 | 2012 | 154 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2021 | 1900 | 0.100 |
Why?
| | Sodium, Dietary | 1 | 1993 | 37 | 0.100 |
Why?
| | Protein Phosphatase 1 | 1 | 2013 | 33 | 0.100 |
Why?
| | Protein Phosphatase 2 | 1 | 2013 | 38 | 0.100 |
Why?
| | Antibodies | 2 | 2013 | 394 | 0.100 |
Why?
| | Immunohistochemistry | 4 | 2018 | 1668 | 0.100 |
Why?
| | Cell Line | 6 | 2021 | 2741 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 1996 | 482 | 0.100 |
Why?
| | Protein Disulfide-Isomerases | 1 | 2012 | 8 | 0.100 |
Why?
| | Substance-Related Disorders | 2 | 1991 | 1010 | 0.100 |
Why?
| | Contractile Proteins | 5 | 1996 | 15 | 0.100 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2005 | 190 | 0.100 |
Why?
| | Receptor, Adenosine A2B | 1 | 2012 | 32 | 0.100 |
Why?
| | Ventricular Function | 2 | 1991 | 61 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1262 | 0.090 |
Why?
| | Aorta | 2 | 2007 | 408 | 0.090 |
Why?
| | Kinetics | 4 | 2011 | 1623 | 0.090 |
Why?
| | Excitation Contraction Coupling | 1 | 2011 | 17 | 0.090 |
Why?
| | Ventricular Pressure | 1 | 2011 | 43 | 0.090 |
Why?
| | Natriuretic Peptides | 1 | 2011 | 9 | 0.090 |
Why?
| | Disease Progression | 3 | 2009 | 2604 | 0.090 |
Why?
| | Hyperbaric Oxygenation | 1 | 2011 | 38 | 0.090 |
Why?
| | Desmin | 1 | 2010 | 24 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 1991 | 57 | 0.090 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 78 | 0.090 |
Why?
| | Peptide Fragments | 2 | 2007 | 688 | 0.090 |
Why?
| | Epoprostenol | 3 | 1986 | 134 | 0.090 |
Why?
| | Chest Pain | 1 | 1990 | 89 | 0.090 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 98 | 0.080 |
Why?
| | Promoter Regions, Genetic | 6 | 1994 | 1199 | 0.080 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 82 | 0.080 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2012 | 209 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 5 | 2012 | 2272 | 0.080 |
Why?
| | Cyclic AMP | 3 | 2008 | 231 | 0.080 |
Why?
| | Cardiovascular Physiological Phenomena | 2 | 2006 | 41 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2002 | 420 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2011 | 140 | 0.080 |
Why?
| | Aged | 9 | 2025 | 21974 | 0.080 |
Why?
| | Reactive Oxygen Species | 2 | 2002 | 583 | 0.080 |
Why?
| | Biopsy | 1 | 2013 | 1079 | 0.080 |
Why?
| | Energy Metabolism | 3 | 2007 | 833 | 0.080 |
Why?
| | Blotting, Northern | 2 | 2001 | 198 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2012 | 418 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2022 | 2765 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2011 | 303 | 0.080 |
Why?
| | Sex Factors | 2 | 2013 | 1951 | 0.080 |
Why?
| | Platelet Aggregation | 3 | 1986 | 94 | 0.080 |
Why?
| | MicroRNAs | 2 | 2015 | 674 | 0.080 |
Why?
| | Adult | 11 | 2020 | 35299 | 0.080 |
Why?
| | Toxicogenetics | 1 | 2008 | 1 | 0.080 |
Why?
| | Mitochondria | 1 | 2014 | 855 | 0.080 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 488 | 0.070 |
Why?
| | Digoxin | 1 | 2008 | 27 | 0.070 |
Why?
| | Biological Transport | 2 | 2002 | 396 | 0.070 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.070 |
Why?
| | Cell Hypoxia | 2 | 2019 | 228 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2007 | 510 | 0.070 |
Why?
| | Mutation | 2 | 2018 | 3696 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 2 | 2022 | 315 | 0.070 |
Why?
| | Embryo, Mammalian | 2 | 2020 | 226 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2002 | 283 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 456 | 0.070 |
Why?
| | RNA | 2 | 2006 | 881 | 0.070 |
Why?
| | Consensus Sequence | 1 | 2007 | 72 | 0.070 |
Why?
| | Protein Conformation | 1 | 2010 | 854 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2001 | 1951 | 0.070 |
Why?
| | Base Sequence | 5 | 1994 | 2137 | 0.070 |
Why?
| | Ligation | 1 | 2007 | 86 | 0.070 |
Why?
| | Biophysical Phenomena | 1 | 2007 | 64 | 0.070 |
Why?
| | Clinical Medicine | 1 | 2007 | 21 | 0.070 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2007 | 45 | 0.070 |
Why?
| | Pregnancy, Animal | 1 | 1987 | 52 | 0.070 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 19 | 0.070 |
Why?
| | Thyroid Hormones | 3 | 1993 | 54 | 0.070 |
Why?
| | Oxidation-Reduction | 2 | 2007 | 1003 | 0.070 |
Why?
| | Chloramphenicol O-Acetyltransferase | 4 | 1994 | 37 | 0.070 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2007 | 122 | 0.070 |
Why?
| | Nitroimidazoles | 1 | 2006 | 9 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2006 | 27 | 0.060 |
Why?
| | Butyrates | 1 | 2007 | 56 | 0.060 |
Why?
| | Fibrosis | 2 | 2015 | 513 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 428 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2012 | 14471 | 0.060 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2006 | 60 | 0.060 |
Why?
| | DNA-Binding Proteins | 2 | 2006 | 1423 | 0.060 |
Why?
| | Heat-Shock Proteins | 1 | 2006 | 134 | 0.060 |
Why?
| | Heart Atria | 1 | 1986 | 128 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2013 | 3339 | 0.060 |
Why?
| | Swimming | 5 | 1990 | 47 | 0.060 |
Why?
| | Age Factors | 3 | 2008 | 3122 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2710 | 0.060 |
Why?
| | Transcription Factors | 2 | 2006 | 1635 | 0.060 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 33 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1997 | 522 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 328 | 0.060 |
Why?
| | Phenylephrine | 2 | 2021 | 74 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2007 | 245 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2004 | 89 | 0.060 |
Why?
| | Osteopontin | 1 | 2004 | 30 | 0.060 |
Why?
| | Protein Kinase C-delta | 2 | 2002 | 44 | 0.060 |
Why?
| | Animals, Genetically Modified | 1 | 2005 | 231 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2345 | 0.060 |
Why?
| | Potassium Channels | 1 | 2025 | 144 | 0.060 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 152 | 0.060 |
Why?
| | Ventricular Myosins | 1 | 2004 | 36 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2025 | 10162 | 0.050 |
Why?
| | Drug Resistance | 1 | 2004 | 165 | 0.050 |
Why?
| | Anticoagulants | 1 | 2008 | 634 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 152 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 636 | 0.050 |
Why?
| | Up-Regulation | 2 | 2007 | 823 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2719 | 0.050 |
Why?
| | Rats, Inbred F344 | 4 | 1997 | 255 | 0.050 |
Why?
| | Mutagenesis | 1 | 2004 | 181 | 0.050 |
Why?
| | Calcium-Transporting ATPases | 3 | 1993 | 40 | 0.050 |
Why?
| | Exercise Therapy | 1 | 1987 | 413 | 0.050 |
Why?
| | Cytokines | 1 | 2011 | 1994 | 0.050 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2002 | 30 | 0.050 |
Why?
| | Mannitol | 1 | 2002 | 35 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 52 | 0.050 |
Why?
| | Massachusetts | 1 | 2022 | 158 | 0.050 |
Why?
| | Osmolar Concentration | 1 | 2002 | 165 | 0.050 |
Why?
| | Chromones | 1 | 2002 | 45 | 0.050 |
Why?
| | Hydroxyproline | 1 | 2001 | 22 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 110 | 0.050 |
Why?
| | Pulsatile Flow | 1 | 2002 | 59 | 0.050 |
Why?
| | GTP-Binding Proteins | 1 | 2002 | 155 | 0.050 |
Why?
| | United States | 3 | 2022 | 13840 | 0.050 |
Why?
| | Muscles | 3 | 1994 | 322 | 0.050 |
Why?
| | Androstadienes | 1 | 2002 | 106 | 0.050 |
Why?
| | Flavonoids | 1 | 2001 | 78 | 0.050 |
Why?
| | Lac Operon | 1 | 2001 | 45 | 0.050 |
Why?
| | Hypertrophy | 1 | 2001 | 115 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 313 | 0.050 |
Why?
| | beta-Galactosidase | 1 | 2001 | 76 | 0.050 |
Why?
| | Glucose | 2 | 2007 | 983 | 0.050 |
Why?
| | Proline | 1 | 2001 | 76 | 0.050 |
Why?
| | Morpholines | 1 | 2002 | 122 | 0.050 |
Why?
| | Immunoblotting | 1 | 2001 | 301 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2002 | 366 | 0.040 |
Why?
| | American Heart Association | 1 | 2022 | 297 | 0.040 |
Why?
| | Calcium Channels, L-Type | 1 | 2002 | 113 | 0.040 |
Why?
| | Models, Chemical | 1 | 2002 | 263 | 0.040 |
Why?
| | Sarcoplasmic Reticulum | 2 | 1993 | 44 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2022 | 378 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 164 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 35 | 0.040 |
Why?
| | Cardiac Pacing, Artificial | 3 | 1998 | 85 | 0.040 |
Why?
| | Protein Kinases | 1 | 2002 | 308 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1856 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 368 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2018 | 2064 | 0.040 |
Why?
| | Protein Transport | 1 | 2001 | 421 | 0.040 |
Why?
| | Carotid Arteries | 1 | 2001 | 194 | 0.040 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 1999 | 19 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 433 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 1999 | 51 | 0.040 |
Why?
| | Qa-SNARE Proteins | 1 | 2018 | 14 | 0.040 |
Why?
| | Organ Culture Techniques | 2 | 2007 | 148 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2018 | 19 | 0.040 |
Why?
| | Biomechanical Phenomena | 2 | 1996 | 763 | 0.040 |
Why?
| | Action Potentials | 2 | 2015 | 469 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2018 | 41 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 43 | 0.040 |
Why?
| | Tachycardia | 1 | 1998 | 56 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 108 | 0.040 |
Why?
| | Cell Membrane | 1 | 2002 | 725 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 431 | 0.040 |
Why?
| | Hypertension, Renal | 2 | 1989 | 16 | 0.040 |
Why?
| | Cell Survival | 1 | 2001 | 1076 | 0.040 |
Why?
| | Blood Platelets | 3 | 1986 | 377 | 0.040 |
Why?
| | Protein Biosynthesis | 2 | 1997 | 398 | 0.040 |
Why?
| | Fatty Acids | 1 | 2021 | 417 | 0.040 |
Why?
| | Streptozocin | 1 | 1997 | 16 | 0.040 |
Why?
| | Research Design | 2 | 2022 | 1036 | 0.040 |
Why?
| | Electrocardiography | 2 | 1991 | 608 | 0.040 |
Why?
| | Epinephrine | 3 | 1988 | 140 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2018 | 120 | 0.040 |
Why?
| | Prazosin | 1 | 1997 | 23 | 0.040 |
Why?
| | Death, Sudden | 1 | 1997 | 24 | 0.040 |
Why?
| | Adrenergic alpha-Agonists | 1 | 1997 | 28 | 0.040 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 1998 | 126 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 703 | 0.040 |
Why?
| | Pharmacogenomic Variants | 1 | 2017 | 35 | 0.040 |
Why?
| | Models, Molecular | 1 | 2002 | 1484 | 0.030 |
Why?
| | Adenosine Triphosphate | 3 | 2011 | 469 | 0.030 |
Why?
| | Threonine | 1 | 1997 | 44 | 0.030 |
Why?
| | Integrases | 1 | 2018 | 118 | 0.030 |
Why?
| | Diastole | 2 | 1988 | 148 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2012 | 458 | 0.030 |
Why?
| | Europe | 1 | 2018 | 360 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 385 | 0.030 |
Why?
| | Biomarkers | 2 | 2013 | 3893 | 0.030 |
Why?
| | Alanine | 1 | 1997 | 141 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1018 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 445 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 225 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1997 | 359 | 0.030 |
Why?
| | Dogs | 1 | 1997 | 368 | 0.030 |
Why?
| | Peptides | 1 | 2001 | 915 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 1993 | 87 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2016 | 77 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 573 | 0.030 |
Why?
| | DNA Methylation | 1 | 2020 | 607 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 530 | 0.030 |
Why?
| | MEF2 Transcription Factors | 1 | 2015 | 61 | 0.030 |
Why?
| | Creatine Kinase | 2 | 1997 | 73 | 0.030 |
Why?
| | Histones | 1 | 2020 | 588 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 131 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 164 | 0.030 |
Why?
| | Phosphofructokinase-1 | 1 | 2014 | 7 | 0.030 |
Why?
| | T-Box Domain Proteins | 1 | 2015 | 96 | 0.030 |
Why?
| | Glucose Transporter Type 4 | 1 | 2014 | 39 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 1994 | 50 | 0.030 |
Why?
| | Luciferases | 2 | 1992 | 147 | 0.030 |
Why?
| | Antibody Specificity | 2 | 2013 | 182 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1358 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2014 | 38 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 324 | 0.030 |
Why?
| | Troponin | 1 | 1994 | 50 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 1994 | 43 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1200 | 0.030 |
Why?
| | Cytochalasin B | 1 | 1974 | 17 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1974 | 42 | 0.030 |
Why?
| | Oxygen Consumption | 3 | 1997 | 671 | 0.030 |
Why?
| | Connexin 43 | 1 | 1994 | 29 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1689 | 0.030 |
Why?
| | Adenoviridae | 1 | 1994 | 189 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 1997 | 1291 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 169 | 0.030 |
Why?
| | Norepinephrine | 3 | 1992 | 210 | 0.030 |
Why?
| | Thyroxine | 1 | 1994 | 62 | 0.030 |
Why?
| | Cytomegalovirus | 1 | 1993 | 152 | 0.030 |
Why?
| | Erythrocytes | 2 | 1977 | 673 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2012 | 28 | 0.020 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 37 | 0.020 |
Why?
| | Avian Sarcoma Viruses | 1 | 1992 | 4 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1097 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 1994 | 356 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 503 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2012 | 56 | 0.020 |
Why?
| | Genes, Viral | 1 | 1992 | 81 | 0.020 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1992 | 111 | 0.020 |
Why?
| | Rabbits | 3 | 1993 | 775 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2012 | 95 | 0.020 |
Why?
| | Cardioplegic Solutions | 1 | 2011 | 6 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2011 | 29 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 145 | 0.020 |
Why?
| | Buffers | 1 | 2011 | 55 | 0.020 |
Why?
| | Swine | 1 | 2013 | 742 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 195 | 0.020 |
Why?
| | Perfusion | 2 | 1997 | 188 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 2433 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 1991 | 124 | 0.020 |
Why?
| | Antigen Presentation | 1 | 2012 | 205 | 0.020 |
Why?
| | New York City | 1 | 1990 | 80 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 196 | 0.020 |
Why?
| | Education, Medical, Continuing | 1 | 1991 | 121 | 0.020 |
Why?
| | Muscle, Skeletal | 2 | 1997 | 1624 | 0.020 |
Why?
| | Growth Hormone | 1 | 1990 | 96 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 260 | 0.020 |
Why?
| | Gonadal Steroid Hormones | 1 | 1990 | 129 | 0.020 |
Why?
| | Women's Health | 1 | 1992 | 361 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2269 | 0.020 |
Why?
| | T-Lymphocytes | 2 | 1994 | 1923 | 0.020 |
Why?
| | Genes | 1 | 1989 | 226 | 0.020 |
Why?
| | Phosphocreatine | 2 | 1999 | 40 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1938 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 449 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 474 | 0.020 |
Why?
| | Injections, Subcutaneous | 1 | 1988 | 147 | 0.020 |
Why?
| | Cell Size | 1 | 2008 | 87 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2007 | 40 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2007 | 50 | 0.020 |
Why?
| | DNA | 2 | 1991 | 1394 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2007 | 59 | 0.020 |
Why?
| | Risk Factors | 2 | 1991 | 9737 | 0.020 |
Why?
| | Mitral Valve Stenosis | 1 | 1986 | 18 | 0.020 |
Why?
| | Peptide Hormones | 1 | 2006 | 11 | 0.020 |
Why?
| | Mitral Valve Insufficiency | 1 | 1986 | 67 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3021 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7057 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7069 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2007 | 463 | 0.020 |
Why?
| | Phentolamine | 1 | 1985 | 14 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1357 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 1985 | 78 | 0.010 |
Why?
| | Actins | 1 | 1987 | 403 | 0.010 |
Why?
| | Cardiovascular System | 1 | 2006 | 137 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1986 | 367 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 2004 | 54 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 2004 | 92 | 0.010 |
Why?
| | Homeostasis | 1 | 2008 | 606 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1999 | 541 | 0.010 |
Why?
| | Motor Activity | 1 | 1988 | 669 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1614 | 0.010 |
Why?
| | Prognosis | 1 | 1991 | 3780 | 0.010 |
Why?
| | Phenanthridines | 1 | 2002 | 7 | 0.010 |
Why?
| | Benzophenanthridines | 1 | 2002 | 11 | 0.010 |
Why?
| | Papillary Muscles | 1 | 2002 | 14 | 0.010 |
Why?
| | Alkaloids | 1 | 2002 | 25 | 0.010 |
Why?
| | Mesylates | 1 | 2002 | 7 | 0.010 |
Why?
| | Detergents | 1 | 2002 | 45 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2002 | 149 | 0.010 |
Why?
| | Second Messenger Systems | 1 | 2002 | 33 | 0.010 |
Why?
| | Aspirin | 1 | 1985 | 378 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2006 | 573 | 0.010 |
Why?
| | Membrane Potentials | 1 | 2002 | 264 | 0.010 |
Why?
| | Pyrroles | 1 | 2002 | 190 | 0.010 |
Why?
| | Fetus | 2 | 1997 | 765 | 0.010 |
Why?
| | Exercise | 1 | 1992 | 1918 | 0.010 |
Why?
| | Tamoxifen | 1 | 1981 | 200 | 0.010 |
Why?
| | Phosphates | 1 | 2001 | 169 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2001 | 209 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1999 | 45 | 0.010 |
Why?
| | Early Growth Response Protein 1 | 1 | 1999 | 26 | 0.010 |
Why?
| | Binding Sites | 1 | 2002 | 1244 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1998 | 3 | 0.010 |
Why?
| | DNA Ligases | 1 | 1998 | 7 | 0.010 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 1998 | 12 | 0.010 |
Why?
| | Constriction | 1 | 1998 | 42 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1989 | 188 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 181 | 0.010 |
Why?
| | Estrogens | 2 | 1992 | 342 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 1998 | 42 | 0.010 |
Why?
| | Erythrocyte Membrane | 1 | 1977 | 49 | 0.010 |
Why?
| | Carbohydrates | 1 | 1977 | 63 | 0.010 |
Why?
| | Protein Kinase C-alpha | 1 | 1997 | 37 | 0.010 |
Why?
| | beta-Thromboglobulin | 2 | 1986 | 3 | 0.010 |
Why?
| | Thromboxane B2 | 2 | 1986 | 26 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3387 | 0.010 |
Why?
| | Running | 2 | 1988 | 222 | 0.010 |
Why?
| | RNA, Transfer, Leu | 1 | 1994 | 7 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 12349 | 0.010 |
Why?
| | Pregnancy | 1 | 1987 | 6373 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1999 | 658 | 0.010 |
Why?
| | Immune Adherence Reaction | 1 | 1974 | 2 | 0.010 |
Why?
| | Atrophy | 1 | 1994 | 170 | 0.010 |
Why?
| | Leucine | 1 | 1994 | 108 | 0.010 |
Why?
| | Vibrio cholerae | 1 | 1974 | 12 | 0.010 |
Why?
| | Neuraminidase | 1 | 1974 | 24 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1994 | 296 | 0.010 |
Why?
| | Intercellular Junctions | 1 | 1994 | 39 | 0.010 |
Why?
| | Melanoma | 1 | 1981 | 724 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 1027 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1994 | 266 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1994 | 190 | 0.010 |
Why?
| | Chick Embryo | 1 | 1993 | 130 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1981 | 820 | 0.010 |
Why?
| | Immune System | 1 | 1994 | 176 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1993 | 311 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1993 | 324 | 0.010 |
Why?
| | Denervation | 1 | 1992 | 22 | 0.010 |
Why?
| | Oxygen | 1 | 1997 | 901 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 20304 | 0.010 |
Why?
| | Triiodothyronine | 1 | 1991 | 44 | 0.010 |
Why?
| | Sheep | 1 | 1974 | 831 | 0.010 |
Why?
| | Temperature | 1 | 1974 | 632 | 0.010 |
Why?
| | Hypothyroidism | 1 | 1991 | 70 | 0.010 |
Why?
| | Models, Cardiovascular | 1 | 1992 | 190 | 0.010 |
Why?
| | Injections | 1 | 1991 | 173 | 0.010 |
Why?
| | Heart Valve Diseases | 1 | 1992 | 151 | 0.010 |
Why?
| | Orchiectomy | 1 | 1990 | 65 | 0.010 |
Why?
| | Plasmids | 1 | 1991 | 355 | 0.010 |
Why?
| | Hematocrit | 1 | 1990 | 93 | 0.010 |
Why?
| | Ovariectomy | 1 | 1990 | 136 | 0.010 |
Why?
| | DNA Probes | 1 | 1989 | 61 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1989 | 83 | 0.000 |
Why?
| | Chickens | 1 | 1989 | 187 | 0.000 |
Why?
| | Lactates | 1 | 1988 | 83 | 0.000 |
Why?
| | Testosterone | 1 | 1990 | 370 | 0.000 |
Why?
| | Child | 1 | 1986 | 20805 | 0.000 |
Why?
| | Lactic Acid | 1 | 1988 | 294 | 0.000 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1986 | 21 | 0.000 |
Why?
| | Kidney | 1 | 1993 | 1310 | 0.000 |
Why?
| | Lymphatic Metastasis | 1 | 1981 | 317 | 0.000 |
Why?
| | Hemagglutination | 1 | 1977 | 8 | 0.000 |
Why?
| | Mitogens | 1 | 1977 | 58 | 0.000 |
Why?
| | Antibody Formation | 1 | 1977 | 290 | 0.000 |
Why?
| | Lymphocytes | 1 | 1977 | 368 | 0.000 |
Why?
|
|
Buttrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|